| # | Drug | Count |
|---|---|---|
| 0 | EMICIZUMAB | 23 |
| 1 | RITONAVIR | 16 |
| 2 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 12 |
| 3 | IBUPFROFEN | 11 |
| 4 | IBUPROFEN | 11 |
| 5 | IBUPROFEN 200 MG | 11 |
| 6 | IBUPROFEN 200MG | 11 |
| 7 | IBUPROFEN CAPSULE | 11 |
| 8 | IBUPROFEN CAPSULES 200 MG | 11 |
| 9 | IBUPROFEN ORAL | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CONCIZUMAB | 1 | 0.0222 |
| 1 | SHARK CARTILAGE | 1 | 0.0119 |
| 2 | LULICONAZOLE | 1 | 0.0057 |
| 3 | ANTI-INHIBITOR COAGULANT COMPLEX | 6 | 0.0054 |
| 4 | CROTAMITON | 2 | 0.0033 |
| 5 | EMICIZUMAB | 23 | 0.0018 |
| 6 | DARUNAVIR ETHANOLATE AND COBICISTAT | 3 | 0.0017 |
| 7 | EPINASTINE HYDROCHLORIDE | 1 | 0.0009 |
| 8 | CYCLOSERINE | 2 | 0.0009 |
| 9 | CEFUROXIME SODIUM | 1 | 0.0008 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tissue Factor Pathway Inhibitor Antagonist [EPC] | 1 | 0.0222 |
| 1 | Antifibrinolytic Agent [EPC] | 7 | 0.0007 |
| 2 | Chloride Channel Activator [EPC] | 4 | 0.0004 |
| 3 | Protease Inhibitor [EPC] | 17 | 0.0004 |
| 4 | Rifamycin Antimycobacterial [EPC] | 1 | 0.0003 |
| 5 | Cytochrome P450 3A Inhibitor [EPC] | 17 | 0.0003 |
| 6 | Vasopressin V2 Receptor Antagonist [EPC] | 4 | 0.0003 |
| 7 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 15 | 0.0001 |
| 8 | Nonergot Dopamine Agonist [EPC] | 2 | 0.0001 |
| 9 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0001 |